Arkolith/Insider Trading/VIVO/Form 4

Kitzmiller Andrew S.

Executive Vice President & CFOMERIDIAN BIOSCIENCE INC (VIVO) · full profile →Form 4 · filed Jan 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2023Grant(A)8K——19K
Jan 31, 2023Disposed to issuer(D)19K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2023Disposed to issuer(D)5K$9.26$46K0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-001529) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML